Items where authors include "Ma, C.X."

Conference abstract

Goetz, M.P., Wander, S.A., Bachelot, T. et al. (17 more authors) (2024) Open-label, randomized, multicenter, phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib for treating ER+/HER2-, locally advanced or metastatic breast cancer with an ESR1 mutation. [Conference abstract]